Silexion Therapeutics Corp (SLXNW)
CIK 2022416 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 4.2M shares as of May 14, 2026 (10-Q). Share count fell from 8.41B to 8.7M between Dec 31, 2024 and May 8, 2025, a pattern consistent with a reverse split (roughly 1-for-968); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Warrant Type Nine | 1.50B | $4 | — | — |
| Warrant Type Ten | 1.05B | $4 | — | — |
| Warrant Type Seven | 304.2M | $11.32 | — | — |
| Warrant Type Eleven | 105.0M | $5 | — | — |
| Warrant Type Two | 42.6M | $1552.5 | — | — |
| Warrant Type Three | 33.7M | $20.25 | — | — |
| Warrant Type Five | 18.5M | $22.5 | — | — |
| Warrant Type Four | 17.3M | $25.31 | — | — |
| Warrant Type Eight | 10.6M | $14.46 | — | — |
| Warrant Type Six | 10.4M | $27.66 | — | — |
| Warrant Type One | 1.4M | $1552.5 | — | — |
Tranches exactly as the company dimensioned them in its 10-K filed Mar 17, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 8,213 underlying shares, as reported Aug 6, 2024 (10-Q).
Reported exercise price: $24.769 (aggregate figure as tagged; individual tranches vary).
Rough fully diluted estimate: 4.2M = 4.2M O/S + 8,213 warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
No convertible-note facts tagged in the 10-Q filed May 15, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.
Registrations and offerings
Registered offering capacity on live registrations: $17.9Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 3 executed · 7 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full SLXNW workspace